Item Type | Name |
Concept
|
Male
|
Academic Article
|
Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant.
|
Academic Article
|
Impact of Advanced Therapies for Improving Survival to Heart Transplant in Patients with Hypertrophic Cardiomyopathy.
|
Academic Article
|
Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
|
Academic Article
|
Syncope and risk of sudden death in hypertrophic cardiomyopathy.
|
Academic Article
|
Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
|
Academic Article
|
Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.
|
Academic Article
|
Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
|
Academic Article
|
What is the best approach for the assessment of left atrial size? Comparison of various unidimensional and two-dimensional parameters with three-dimensional echocardiographically determined left atrial volume.
|
Academic Article
|
Contrast-enhanced CMR in HCM: what lies behind the bright light of LGE and why it now matters.
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
Academic Article
|
Images in cardiovascular medicine. Overlapping phenotypes: left ventricular noncompaction and hypertrophic cardiomyopathy.
|
Academic Article
|
Effect of Left Ventricular Outflow Tract Obstruction on Left Atrial Mechanics in Hypertrophic Cardiomyopathy.
|
Academic Article
|
Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy.
|
Academic Article
|
Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.
|
Academic Article
|
Anatomic validation of late gadolinium enhancement as evidence of myocardial scarring in LAMP2 cardiomyopathy.
|
Academic Article
|
Comparison of circadian rhythm patterns in Tako-tsubo cardiomyopathy versus ST-segment elevation myocardial infarction.
|
Academic Article
|
Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.
|
Academic Article
|
Response to Letter Regarding Article, "Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy".
|
Academic Article
|
Coronary embolization in hypertrophic cardiomyopathy with left ventricular apical aneurysm.
|
Academic Article
|
Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.
|
Academic Article
|
Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy.
|
Academic Article
|
Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy.
|
Academic Article
|
Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging.
|
Academic Article
|
Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy?
|
Academic Article
|
Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
|
Academic Article
|
Association Between Race and Clinical Profile of Patients Referred for Hypertrophic Cardiomyopathy.
|
Academic Article
|
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.
|
Academic Article
|
Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (?-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
|
Academic Article
|
The 25-year genetic era in hypertrophic cardiomyopathy: revisited.
|
Academic Article
|
Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
|
Academic Article
|
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.
|
Academic Article
|
CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy.
|
Academic Article
|
Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
|
Academic Article
|
Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy.
|
Academic Article
|
How to Image Hypertrophic Cardiomyopathy.
|
Academic Article
|
Relation of Doppler Tissue Imaging Parameters With Heart Failure Progression in Hypertrophic Cardiomyopathy.
|
Academic Article
|
Relation of pulse pressure to blood pressure response to exercise in patients with hypertrophic cardiomyopathy.
|
Academic Article
|
Exploring New and Old Therapies for Obstructive Hypertrophic Cardiomyopathy: Mavacamten in Perspective.
|
Academic Article
|
Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
|
Academic Article
|
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
|
Academic Article
|
Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
|
Academic Article
|
Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
|
Academic Article
|
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.
|
Academic Article
|
Right ventricular involvement in hypertrophic cardiomyopathy.
|
Academic Article
|
Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy.
|
Academic Article
|
Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy.
|
Academic Article
|
The Guidant Affair revisited?but this time with good news.
|
Academic Article
|
Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
|
Academic Article
|
Coexistence of acute takotsubo syndrome and acute coronary syndrome.
|
Academic Article
|
Nonobstructive Hypertrophic Cardiomyopathy: Overlooked But Not Forgotten.
|
Academic Article
|
Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry.
|
Academic Article
|
Three-dimensional Deep Convolutional Neural Networks for Automated Myocardial Scar Quantification in Hypertrophic Cardiomyopathy: A Multicenter Multivendor Study.
|
Academic Article
|
Characteristics of Patients With Obstructive Hypertrophic Cardiomyopathy in Real-World Community-Based Cardiovascular Practices.
|
Academic Article
|
Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance.
|
Academic Article
|
Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy.
|
Academic Article
|
Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.
|
Academic Article
|
Hypertrophic Cardiomyopathy in?Adulthood Associated With Low?Cardiovascular Mortality With Contemporary Management Strategies.
|
Academic Article
|
Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors.
|
Academic Article
|
Role of Exercise Testing in Hypertrophic?Cardiomyopathy.
|
Academic Article
|
Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease.
|
Academic Article
|
Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
|
Academic Article
|
Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy.
|
Academic Article
|
Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
|
Academic Article
|
Safety and Efficacy of Metabolic Modulation?With Ninerafaxstat in?Patients?With Nonobstructive Hypertrophic Cardiomyopathy.
|
Academic Article
|
Peripheral vascular endothelial function in patients with hypertrophic cardiomyopathy.
|
Academic Article
|
Deformation-encoding Deep Learning Transformer for High-Frame-Rate Cardiac Cine MRI.
|
Academic Article
|
A Case of Multiple Ventricular Gradients.
|
Academic Article
|
Underappreciated occurrence of discrete subaortic membranes producing left ventricular outflow obstruction in hypertrophic cardiomyopathy.
|
Academic Article
|
Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
|
Academic Article
|
New perspectives on the prevalence of hypertrophic cardiomyopathy.
|
Academic Article
|
Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation.
|
Academic Article
|
Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.
|
Academic Article
|
Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy.
|
Academic Article
|
Left Ventricular Apex Involvement in Hypertrophic Cardiomyopathy.
|
Academic Article
|
Usefulness of Global Longitudinal Strain to Predict Heart Failure Progression in Patients With Nonobstructive Hypertrophic Cardiomyopathy.
|
Academic Article
|
Cardiovascular magnetic resonance imaging for bicuspid aortic valve syndrome: the time is now.
|
Academic Article
|
Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
|
Academic Article
|
Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
|
Academic Article
|
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4.
|
Academic Article
|
Papillary muscle insertion directly into the anterior mitral leaflet in hypertrophic cardiomyopathy, its identification and cause of outflow obstruction by cardiac magnetic resonance imaging, and its surgical management.
|
Academic Article
|
Hypertrophic Cardiomyopathy in "Real-World" Community Cardiology Practice.
|
Academic Article
|
Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
|
Academic Article
|
Distinctive Hypertrophic Cardiomyopathy Anatomy and Obstructive Physiology in Patients Admitted With Takotsubo Syndrome.
|
Academic Article
|
Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy.
|
Academic Article
|
The case for myocardial ischemia in hypertrophic cardiomyopathy.
|
Academic Article
|
Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
|
Academic Article
|
Development and Validation of a Clinical Predictive Model for Identifying Hypertrophic Cardiomyopathy Patients at Risk for Atrial Fibrillation: The HCM-AF Score.
|
Academic Article
|
Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach.
|
Academic Article
|
Left ventricular twist mechanics in hypertrophic cardiomyopathy assessed by three-dimensional speckle tracking echocardiography.
|
Academic Article
|
Adult Monozygotic Twins With Hypertrophic Cardiomyopathy and Identical Disease Expression and Clinical Course.
|
Academic Article
|
Moving Beyond the Sarcomere to Explain?Heterogeneity in Hypertrophic?Cardiomyopathy: JACC Review Topic of the Week.
|
Academic Article
|
Hypertrophic cardiomyopathy in childhood: the gradient is not the disease. Excessive use of experimental invasive interventions.
|
Academic Article
|
Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
|
Academic Article
|
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
|
Academic Article
|
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy.
|
Academic Article
|
Clinical Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic Cardiomyopathy.
|
Academic Article
|
Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.
|
Academic Article
|
Chronic Heart Failure Is Infrequently Associated With Renal Dysfunction in Hypertrophic Cardiomyopathy.
|
Academic Article
|
Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction.
|
Academic Article
|
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
|
Academic Article
|
Structurally Normal Hearts Are Uncommonly Associated With Sudden Deaths in Athletes and Young People.
|
Academic Article
|
Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy.
|
Academic Article
|
Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes.
|
Academic Article
|
Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
Academic Article
|
Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy.
|
Academic Article
|
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
|
Academic Article
|
Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy.
|
Academic Article
|
Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
|
Academic Article
|
Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices.
|
Academic Article
|
Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy.
|
Academic Article
|
? Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.
|
Academic Article
|
Clinical Spectrum and Management Implications of Left Ventricular Outflow Obstruction With Mild Ventricular Septal Thickness in Hypertrophic Cardiomyopathy.
|
Academic Article
|
Impact of papillary and trabecular muscles on quantitative analyses of cardiac function in hypertrophic cardiomyopathy.
|
Academic Article
|
Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
|
Academic Article
|
Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States.
|
Academic Article
|
Reply: To PMID 25759101.
|
Academic Article
|
Single Coil Implantable Cardioverter Defibrillator Leads in Patients With Hypertrophic Cardiomyopathy.
|
Academic Article
|
Evidence for Left Ventricular Outflow Tract Obstruction With Minimal Septal Hypertrophy: The Case Grows Stronger for a Multimodality Imaging Strategy for Hypertrophic Cardiomyopathy.
|
Academic Article
|
Clinical Profile of Patients With High-Risk Tako-Tsubo Cardiomyopathy.
|
Academic Article
|
"Speckled" ventricular septum in hypertrophic cardiomyopathy revisited after 30 years.
|
Academic Article
|
Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy.
|
Academic Article
|
Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance.
|
Academic Article
|
Safety, Side Effects and Relative Efficacy of Medications for Rhythm Control of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
|
Academic Article
|
Hypertrophic cardiomyopathy with left ventricular apical aneurysm in brothers.
|
Academic Article
|
Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy With Pulmonary Hypertension.
|
Academic Article
|
Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.
|
Academic Article
|
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
|
Academic Article
|
Impact of Effective Management Strategies on Patients With the Most Extreme Phenotypic Expression of Hypertrophic Cardiomyopathy.
|
Academic Article
|
Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy.
|
Academic Article
|
Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
|
Academic Article
|
Light-chain amyloidosis with echocardiographic features of hypertrophic cardiomyopathy.
|
Academic Article
|
Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
|
Academic Article
|
Risks of the Athletic Field Revisited: Report of Unusual Occurrences of Cardiac Arrest and Sudden Death in Professional Soccer Players.
|
Academic Article
|
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.
|
Academic Article
|
Asymptomatic young man with Danon disease.
|
Academic Article
|
Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation.
|
Academic Article
|
Effect of Spironolactone on Myocardial Fibrosis and Other Clinical Variables in Patients with Hypertrophic Cardiomyopathy.
|
Academic Article
|
Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants.
|
Academic Article
|
Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.
|
Academic Article
|
Hypertrophic Cardiomyopathy With Left?Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.
|
Academic Article
|
Outcomes Over Follow-up =10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
|
Academic Article
|
The ever expanding spectrum of phenotypic diversity in hypertrophic cardiomyopathy.
|
Academic Article
|
Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy.
|
Academic Article
|
Velocity vector imaging in the measurement of left ventricular myocardial mechanics on cardiac magnetic resonance imaging: correlations with echocardiographically derived strain values.
|
Academic Article
|
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy.
|
Academic Article
|
Effect of Aficamten on Cardiac Structure?and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy.
|
Academic Article
|
Effect of Aficamten on Health Status?Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.
|
Academic Article
|
Aficamten and Cardiopulmonary Exercise Test Performance: A Substudy of the SEQUOIA-HCM Randomized Clinical Trial.
|
Academic Article
|
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
|
Academic Article
|
Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
|
Academic Article
|
Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy.
|
Academic Article
|
Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
|
Academic Article
|
Myocardial crypts in hypertrophic cardiomyopathy: the new gang in town.
|
Academic Article
|
Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort Study.
|
Academic Article
|
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.
|
Academic Article
|
Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM.
|
Academic Article
|
Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy.
|
Academic Article
|
Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated for at Least 5?Years.
|
Academic Article
|
Cardiovascular outcomes of glucagon-like peptide-1 agonist in patients with obesity and hypertrophic cardiomyopathy.
|
Academic Article
|
Evidence of Declining Mortality Trends for Hypertrophic Cardiomyopathy in the United States and the Impact of the COVID-19 Pandemic.
|